Status:
COMPLETED
Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19
Lead Sponsor:
Brugmann University Hospital
Conditions:
Covid19
Eligibility:
FEMALE
18+ years
Brief Summary
A new coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) appeared in Wuhan, China and it arrived to Europe 2-3 months later. It infected millions of persons and led to the...
Eligibility Criteria
Inclusion
- Pregnant women with viable fetus after 10 weeks' gestation and known pregnancy outcome during the period starting on February 1st 2020 and ending on November 30th 2020.
Exclusion
- All ongoing pregnancies, those with unknown outcomes, those terminated medically or voluntary, as well as patients with spontaneous abortion before the 11th gestational week.
Key Trial Info
Start Date :
December 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
10925 Patients enrolled
Trial Details
Trial ID
NCT04779749
Start Date
December 8 2020
End Date
September 1 2021
Last Update
September 2 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020
2
Antoine Béclère Hospital
Clamart, France, 92140
3
Hôpital Louis Mourier
Colombes, France, 92700
4
Fondazione Policlinico Universitario Agostino Gemelli
Roma, Italy, 00168